These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31822200)

  • 81. Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
    Arellano-Rodrigo E; López-Guillermo A; Bessell EM; Nomdedeu B; Montserrat E; Graus F
    Eur J Haematol; 2003 Apr; 70(4):219-24. PubMed ID: 12656744
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice.
    Weycker D; Hatfield M; Grossman A; Hanau A; Lonshteyn A; Sharma A; Chandler D
    BMC Cancer; 2019 Feb; 19(1):151. PubMed ID: 30764783
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Inpatient Versus Outpatient Management of Negative Pressure Wound Therapy in Pediatric Patients.
    Santosa KB; Keane AM; Keller M; Olsen MA; Sears ED; Snyder-Warwick AK
    J Surg Res; 2020 Oct; 254():197-205. PubMed ID: 32450421
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Assessment of Healthcare Resource Utilization and Hospitalization Costs in Patients With Relapsed or Refractory Follicular Lymphoma Undergoing CAR-T Cell Therapy With Tisagenlecleucel: Results From the ELARA Study.
    Fowler NH; Dickinson M; Ghosh M; Chen AI; Andreadis C; Tiwari R; Masood A; Ramos R; Jousseaume E; Thieblemont C; Dreyling M; Schuster SJ
    Transplant Cell Ther; 2023 Jan; 29(1):60.e1-60.e4. PubMed ID: 36182104
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cost analysis model of outpatient management of ovarian hyperstimulation syndrome with paracentesis: "tap early and often" versus hospitalization.
    Csokmay JM; Yauger BJ; Henne MB; Armstrong AY; Queenan JT; Segars JH
    Fertil Steril; 2010 Jan; 93(1):167-73. PubMed ID: 18990389
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cost Savings from Reducing Pain Through the Delivery of Integrative Medicine Program to Hospitalized Patients.
    Dusek JA; Griffin KH; Finch MD; Rivard RL; Watson D
    J Altern Complement Med; 2018 Jun; 24(6):557-563. PubMed ID: 29474095
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases.
    Seal B; Sullivan SD; Ramsey SD; Asche CV; Shermock K; Sarma S; Zagadailov EA; Farrelly E; Eaddy M
    Appl Health Econ Health Policy; 2014 Oct; 12(5):547-57. PubMed ID: 25005491
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Healthcare cost of type 1 diabetes mellitus in new-onset children in a hospital compared to an outpatient setting.
    Jasinski CF; Rodriguez-Monguio R; Tonyushkina K; Allen H
    BMC Pediatr; 2013 Apr; 13():55. PubMed ID: 23587308
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Safety and feasibility of outpatient high-dose cytarabine and intermediate-dose cytarabine for consolidation therapy in acute myeloid leukemia.
    Li W; Richter K; Lee J; McCarthy K; Kubal T
    J Oncol Pharm Pract; 2022 Dec; 28(8):1812-1818. PubMed ID: 34609924
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Risk Factors Associated With Unplanned Acute Care in Outpatient Chemotherapy With Oral Anticancer Drugs as Monotherapy or Combination Therapy With Injectable Anticancer Drugs.
    Kawasumi K; Kawano Y; Kujirai A; Mano Y; Matsui R; Maeda-Minami A; Yamamoto Y; Negishi K; Shimada S; Yamaguchi M; Nagata M; Aoyama T
    Anticancer Res; 2021 Nov; 41(11):5827-5834. PubMed ID: 34732458
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Improving the Care and Cost of Treating Community-Acquired Stage 3 and 4 Decubitus Ulcers.
    Le PB; Kelly-Brown J; Yturralde KJ; McGreevy DJ; Lindler L; Hurley DM; Friedman HI
    Ann Plast Surg; 2024 Jun; 92(6S Suppl 4):S408-S412. PubMed ID: 38857005
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evaluating the appropriateness of chemotherapy in a low-resource cancer centre in sub-Saharan Africa.
    Serra P; Katabalo DM; Masalu N; Amadori D; Bugingo S; Foca F; Bravaccini S; Donati C; Bucchi L; Masini C
    Cancer Med; 2020 Jan; 9(1):133-140. PubMed ID: 31721474
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Increased efficiency of endocrine procedures performed in an ambulatory operating room.
    Clark N; Schneider DF; Vrabec S; Bauer PS; Chen H; Sippel RS
    J Surg Res; 2013 Sep; 184(1):200-3. PubMed ID: 23702288
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cost effectiveness of integrated medicine in patients with cancer receiving anticancer chemotherapy.
    Coriat R; Boudou-Rouquette P; Durand JP; Forgeot d'Arc P; Martin I; Mir O; Ropert S; Alexandre J; Goldwasser F
    J Oncol Pract; 2012 Jul; 8(4):205-10. PubMed ID: 23180982
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Costs by Site of Service for Commercially-Insured Patients with Metastatic Pancreatic Cancer Receiving Guideline-Recommended Chemotherapy: Comparing Community Oncology and Hospital Outpatient Settings.
    Tomicki S; Dieguez G; DeStephano D; Chang M; Cockrum P
    Clinicoecon Outcomes Res; 2022; 14():653-663. PubMed ID: 36250036
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Inpatient Lung Transplant Evaluation Is Associated With Increased Risk of Morbidity, Mortality, and Cost of Care After Transplant.
    Olson MT; Elnahas S; Roy SB; Kang P; Knight T; Grief KE; Krushelniski B; Walia R; Bremner RM; Smith MA
    Prog Transplant; 2021 Sep; 31(3):219-227. PubMed ID: 34278840
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy.
    Judson TJ; Bennett AV; Rogak LJ; Sit L; Barz A; Kris MG; Hudis CA; Scher HI; Sabattini P; Schrag D; Basch E
    J Clin Oncol; 2013 Jul; 31(20):2580-5. PubMed ID: 23733753
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Secondary review reduced inpatient MRI orders and avoidable hospital days.
    Robinson NB; Gao M; Patel PA; Davidson KW; Peacock J; Herron CR; Baker AC; Hentel KA; Oh PS
    Clin Imaging; 2022 Feb; 82():156-160. PubMed ID: 34844100
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prolonged low intensity EPOCH-rituximab has improved toxicity in Burkitt lymphoma compared with standard short, high intensity therapy.
    Shahbazi S; Peer CJ; Figg WD
    Cancer Biol Ther; 2014 Sep; 15(9):1117-9. PubMed ID: 24919059
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.